Site-Specific GlcNAcylation of Human Erythrocyte Proteins

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 3.
FIG. 3.

Mapping O-GlcNAc sites and site-specific quantitation. A: Scheme for enrichment of O-GlcNAc peptides. B: Structure (inset) and CAD fragmentation of fully tagged O-GlcNAc peptide (YSPgTSPSK). [M+GlcNAc+GalNAz+Biotin+3H]3+ = 614.6, [M+H]+ = 866.5, [M+GlcNAc+H]+ = 1069.6. C: Flow chart for comparing site-specific O-GlcNAc RORs. Inset: Scheme for solid-phase BEMAD. D: Protein expression level dynamics in diabetic erythrocytes compared with normal erythrocytes. E: Specificity control for the enrichment and site-mapping. Samples were untreated or treated with hexosaminidase at 37°C for 48 h before going through the work flow. Base peak chromatograms are shown. NL, intensity in counts normalized to 1 s; TBTA, Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine; TCEP, Tris(2-carboxyethyl)phosphine.

This Article

  1. Diabetes vol. 58 no. 2 309-317